Two new polls give different idea of public opinion on healthcare reform
One has many more Americans wanting reform than the other.
Did you know…
…that researchers are trying to target and fight tumors with bee venom?
Hospitals round-up for 9/29
The news on Brownsville Tri-County Hospital, Wilkes-Barre General Hospital, Lancaster General Hospital, Taylor Nursing & Rehabilitation Center, and Windber Medical Center.
Is it fair that older people pay more for private health insurance?
The Associated Press interviews people in the healthcare industry.
WSJ: Where the worst germs lurk
In light of the swine flu scare, the Wall Street Journal reminds us where to be the most careful about germs.
Probiotics: Beneficial, or hyped-up?
A growing number of products from popular food manufacturers contain micro-organisms, called probiotics, that the manufacturers claim will help consumers’ digestive health, among other benefits.
Two Professionals Join Investment Team of BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania
Genomeweb reports:
Shahram Hejazi and Marie Lindner have joined the new investment team of BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, a state-created seed- and pre-seed investor in life sciences companies.
Hejazi is responsible for BioAdvance investments in device, diagnostics and imaging companies, as well as working with mid- to late-stage molecular imaging, life science tools and [...]
Merck acquires rights to CSL flu vaccine
Merck & Co. Inc. has acquired the U.S. rights to market and distribute a seasonal flu vaccine made by an Australian drug company.
ViroPharma shares rise as analyst boosts outlook
ViroPharma Inc., of Exton recieved priase from analyst who upgraded the stock. Analyst cited potential for sales of Cinryze and minimal impact to sales from generic versions.
Abbot buys Solvay pharma operations
Abbot buys Solvay pharma operations. Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.